Greenfern Industries (NZSE:GFI) Capex-to-Revenue : 1.19 (As of Mar. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Greenfern Industries Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Greenfern Industries's Capital Expenditure for the six months ended in Mar. 2023 was NZ$-0.66 Mil. Its Revenue for the six months ended in Mar. 2023 was NZ$0.55 Mil.

Hence, Greenfern Industries's Capex-to-Revenue for the six months ended in Mar. 2023 was 1.19.

Greenfern Industries Capex-to-Revenue Historical Data

The historical data trend for Greenfern Industries's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenfern Industries Capex-to-Revenue Chart

Greenfern Industries Annual Data

Trend

Mar22

Mar23

Capex-to-Revenue

2.52

1.19

Greenfern Industries Semi-Annual Data
	Mar22	Mar23
Capex-to-Revenue	2.52	1.19

Competitive Comparison of Greenfern Industries's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Greenfern Industries's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Greenfern Industries's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Greenfern Industries's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Greenfern Industries's Capex-to-Revenue falls into.

Greenfern Industries Capex-to-Revenue Calculation

Greenfern Industries's Capex-to-Revenue for the fiscal year that ended in Mar. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-0.656)	/	0.551
	=	1.19

Greenfern Industries's Capex-to-Revenue for the quarter that ended in Mar. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-0.656)	/	0.551
	=	1.19

Greenfern Industries (NZSE:GFI) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Greenfern Industries Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Greenfern Industries's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Greenfern Industries (NZSE:GFI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Greenfern Industries Ltd (NZSE:GFI) » Definitions » Capex-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

115 Queen Street, Level 8, General Capital House, Auckland, NTL, NZL, 1040

Website

https://www.gfi.nz

Greenfern Industries Ltd is committed to the environmentally friendly production of medicinal cannabis and hemp-based products. It operates in two segments, Cannabis and therapeutics products the operations of this segment reflect the activities of manufacture and distribution of cannabis products, Electricity generation this segment includes the generation and distribution of electricity. The hemp seed and its by-products are used for a range of different products from a high protein ingredient in a plant-based meat substitute, a hemp-based skincare range, and hemp-based beverages amongst other things.